Current needs for human and medical genomics research infrastructure in low and middle income countries

Genomics has facilitated the identification of a large number of genetic variants that are causal and/or risk factors for both rare and common human diseases. Low and middle income countries (LMIC) represent a large proportion of the human population, with distinct health priorities from the develop...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2016
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/26358
Acceso en línea:
https://doi.org/10.1136/jmedgenet-2015-103631
https://repository.urosario.edu.co/handle/10336/26358
Palabra clave:
Article
Bioinformatics
Biomedicine
Economic development
Exome
Funding
Genetic analysis
Genomics
Genotype
Health care facility
Health care planning
Human
Income
Low and middle income country
Medical research
Next generation sequencing
Priority journal
Program cost effectiveness
Sequence analysis
Developing country
Genomics
High throughput sequencing
Human genome
Medical genetics
Medical research
Pharmacogenetics
Procedures
Trends
Biomedical Research
Developing Countries
Genetics
Medical
Genome
Human
Genomics
High-Throughput Nucleotide Sequencing
Humans
Pharmacogenetics
Rights
License
Restringido (Acceso a grupos específicos)
Description
Summary:Genomics has facilitated the identification of a large number of genetic variants that are causal and/or risk factors for both rare and common human diseases. Low and middle income countries (LMIC) represent a large proportion of the human population, with distinct health priorities from the developed world. There have been some initiatives in LMIC focused on medical genomics research. We review successful examples of existing genomics centres in LMIC and suggest some recommendations to develop the research infrastructure that is needed in LMIC. There is an urgent need to improve local infrastructures of many LMIC to carry out medical genomics research.